| 000 | 01810 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517012230.0 | ||
| 264 | 0 | _c20150521 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-015-1654-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorin-Brureau, Mélanie | |
| 245 | 0 | 0 |
_aEnhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cApr 2015 |
||
| 300 |
_a447-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBrain Neoplasms _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGlioma _ximmunology |
| 650 | 0 | 4 |
_aImmunity, Cellular _ximmunology |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xgenetics |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_abeta 2-Microglobulin _xphysiology |
| 700 | 1 | _aHooper, Kirsten M | |
| 700 | 1 | _aProsniak, Michael | |
| 700 | 1 | _aSauma, Sami | |
| 700 | 1 | _aHarshyne, Larry A | |
| 700 | 1 | _aAndrews, David W | |
| 700 | 1 | _aHooper, D Craig | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 64 _gno. 4 _gp. 447-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-015-1654-z _zAvailable from publisher's website |
| 999 |
_c24525168 _d24525168 |
||